Background Community-acquired pneumonia (CAP) is associated with high morbidity and
mortality. In the present study, we aimed to assess the effect of corticosteroids on all-cause …

Background Community-acquired pneumonia (CAP) is a leading cause of morbidity and
mortality. Corticosteroids may be a beneficial adjunct in the treatment of bacterial …

Background The role of corticosteroids in the treatment of community-acquired pneumonia
(CAP) remains uncertain. We conducted an updated meta-analysis to investigate the …

Background: Community-acquired pneumonia (CAP) is common and often severe. Purpose:
To examine the effect of adjunctive corticosteroid therapy on mortality, morbidity, and …

Background Corticosteroids are an option in the treatment of community-acquired
pneumonia (CAP). However, the benefits and adverse effects of corticosteroids, especially in …

Background The benefit of corticosteroids in community-acquired pneumonia (CAP) remains
controversial. We did a meta-analysis to include all the randomized controlled trials (RCTs) …

Introduction International guidelines provide heterogenous guidance on use of
corticosteroids for community-acquired pneumonia (CAP). Methods We performed a …

Background Adjunctive corticosteroids therapy is an attractive option for community-
acquired pneumonia (CAP) treatment. However, the effectiveness of adjunctive …

Background: The systemic use of corticosteroids for patients in severe community-acquired
pneumonia (CAP) remains disputed in clinical practice. We undertook a systematic review …

BACKGROUND: The debate about the efficacy of corticosteroids in the treatment of severe
community-acquired pneumonia (CAP) is still a longstanding dilemma. We performed a …